Tatsunori Maekawa

发表

Leucine-Rich Repeat Kinase 2 Controls Inflammatory Cytokines Production through NF-κB Phosphorylation and Antigen Presentation in Bone Marrow-Derived Dendritic Cells

M. Kubo, F. Obata, K. Eshima, 2020, International journal of molecular sciences.

LRRK2 Phosphorylates Tubulin-Associated Tau but Not the Free Molecule: LRRK2-Mediated Regulation of the Tau-Tubulin Association and Neurite Outgrowth

F. Obata, Fumitaka Kawakami, Tatsunori Maekawa, 2012, PloS one.

Leucine‐rich repeat kinase 2 regulates tau phosphorylation through direct activation of glycogen synthase kinase‐3β

Fumitaka Kawakami, Tatsunori Maekawa, E. Ohta, 2014, The FEBS journal.

Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia

F. Obata, T. Sasaoka, M. Farrer, 2016, BMC Neuroscience.

Age-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen.

M. Kubo, F. Obata, Tatsunori Maekawa, 2010, Biochemical and biophysical research communications.

LRRK2 Inhibition Ameliorates Dexamethasone-Induced Glucose Intolerance via Prevents Impairment in GLUT4 Membrane Translocation in Adipocytes.

M. Kanzaki, M. Kubo, F. Kojima, 2020, Biological & pharmaceutical bulletin.

The I2020T Leucine-rich repeat kinase 2 transgenic mouse exhibits impaired locomotive ability accompanied by dopaminergic neuron abnormalities

Y. Sasaki, F. Obata, Tatsunori Maekawa, 2012, Molecular Neurodegeneration.

I(2020)T leucine-rich repeat kinase 2, the causative mutant molecule of familial Parkinson's disease, has a higher intracellular degradation rate than the wild-type molecule.

S. Hattori, F. Obata, Fumitaka Kawakami, 2009, Biochemical and biophysical research communications.

Altered expression of amino acid transporter LATs of intestinal cells in 5-fluorouracil-induced intestinal mucosal inflammation

W. Koizumi, S. Tamaki, Fumitaka Kawakami, 2020 .

Histamine H2-Receptor Antagonists Improve Non-Steroidal Anti-Inflammatory Drug-Induced Intestinal Dysbiosis

S. Tamaki, Fumitaka Kawakami, Tatsunori Maekawa, 2020, International journal of molecular sciences.

Elemental diet moderates 5-fluorouracil-induced gastrointestinal mucositis through mucus barrier alteration

W. Koizumi, Hajime Yamamoto, Fumitaka Kawakami, 2015, Cancer Chemotherapy and Pharmacology.

Influence of H 2-receptor antagonists on intestinal mucositis induced by 5-fluorouracil in rats

Fumitaka Kawakami, Tatsunori Maekawa, R. Kawashima, 2016 .

LRRK2: An Emerging New Molecule in the Enteric Neuronal System That Quantitatively Regulates Neuronal Peptides and IgA in the Gut

M. Kubo, Fumitaka Kawakami, Tatsunori Maekawa, 2017, Digestive Diseases and Sciences.

Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia

F. Obata, T. Sasaoka, M. Farrer, 2016, BMC Neuroscience.

LRRK2 is expressed in B-2 but not in B-1 B cells, and downregulated by cellular activation

M. Kubo, F. Obata, K. Eshima, 2010, Journal of Neuroimmunology.

Nrf2 Expression Is Decreased in LRRK2 Transgenic Mouse Brain and LRRK2 Overexpressing SH-SY5Y Cells.

S. Tamaki, Fumitaka Kawakami, Tatsunori Maekawa, 2023, Biological & pharmaceutical bulletin.

Leucine-Rich Repeat Kinase 2 Is Associated With Activation of the Paraventricular Nucleus of the Hypothalamus and Stress-Related Gastrointestinal Dysmotility

Fumitaka Kawakami, Tatsunori Maekawa, R. Kawashima, 2019, Front. Neurosci..

Leucine-rich repeat kinase 2 is a regulator of B cell function, affecting homeostasis, BCR signaling, IgA production, and TI antigen responses

M. Kubo, F. Obata, T. Sasaoka, 2016, Journal of Neuroimmunology.

The mouse/human cross-species heterodimer of leucine-rich repeat kinase 2: Possible significance in the transgenic model mouse of Parkinson’s disease

F. Obata, Tatsunori Maekawa, E. Ohta, 2015, Neuroscience Letters.

Interleukin-13 Mediates Non-Steroidal Anti-Inflammatory-Drug-Induced Small Intestinal Mucosal Injury with Ulceration

Fumitaka Kawakami, Tatsunori Maekawa, Rei Kawashima, 2023, International journal of molecular sciences.